Skip to Main Content

Clinical Trials

The following trials are currently enrolling participants at Metro Health. For more information about any of them, email


Expanded Access to Convalescent Plasma for the Treatment of Patients with COVID-19
Condition: Severe or life threatening COVID-19 infection
To grant access to potentially beneficial convalescent plasma to adult patients diagnosed with SARS-CoV-2 (COVID-19).
Investigators: Eric Feucht, MD; Jeffrey Fletcher, MD


University of Michigan Health-West is a member of the Cancer Research Consortium of West Michigan (CRCWM). Visit for a listing of available clinical trials.


ASPIRE: Anticoagulation in Intracerebral Hemorrhage (ICH) Survivors for Stroke Prevention and Recovery

Condition: Intracerebral hemorrhage and Non-Lobar Atrial Fibrillation
To determine if apixiban is superior to aspirin for the prevention of the composite outcomes of a stroke in patients with recent intracerebral hemorrhage (ICH) and atrial fibrillation (AF).
Investigators: Augusto Elias, MD; Jeffrey Fletcher, MD

SATURN: Statins Use in Intracerebral Hemorrhage Patients

Condition: Intracerebral hemorrhage on statin therapy
To determine whether continuation vs. discontinuation of statin drugs is the best strategy after a lobar intracerebral hemorrhage (ICH).
Investigators: Augusto Elias, MD; Jeffrey Fletcher, MD

Peripheral Artery Disease

Condition: Peripheral Artery Disease (PAD)
Goal: To learn more about the benefits of using the Lutonix Drug-Coated Balloon catheter (formerly, Moxy Drug-Coated Balloon catheter) and to gather more data to show it’s safe when treating people with narrowed leg blood vessels.
Principal Investigator: Larry Diaz, MD

PRIME Registry
Condition: Peripheral Artery Disease (PAD)
Purpose: Evaluate immediate and long-term outcomes of endovascular revascularization in patients with Critical Limb Ischemia (CLI) and advanced PAD.
Principal Investigator: Larry Diaz, MD

Heart Disease

Assessment of Primary Prevention Patients Receiving An ICD – Systematic Evaluation of ATP
Condition: Fast or Irregular Heart Rhythms
Purpose: To understand the role of antitachycardia pacing (ATP) in patients receiving ICD therapy.
Principal Investigator: Matthew Sevensma, DO

Analysis of Both Sex and Device Specific Factors on Outcomes in Patients with Non-Ischemic Cardiomyopathy
Condition: Fast or Irregular Heart Rhythms
Purpose: To confirm the long-term safety and reliability of the BIOTRONIK ICD or CRT-D.
Principal Investigator: Matthew Sevensma, DO

A Prospective, Multicenter Study to Evaluate the Safety and Performance of the CAT RX Aspiration Catheter in Patients with a High Thrombus Burden Acute Coronary Vessel Occlusion
Condition: Heart attack
Purpose: To confirm the safety and performance of the CAT RX Aspiration Catheter in patients with a clot in the heart resulting in a heart attack.
Principal investigator: Larry Diaz, MD

Multi-center, cross-sectional, epidemiological study to characterize the prevalence and distribution of lipoprotein(a) levels among patients with established cardiovascular disease
Condition: Heart Attack, Stroke, or Peripheral Vascular Disease
Purpose: To determine if patients have an elevated lipoprotein(a) lab value.
Principal investigator: Rony Gorges, MD


A Longitudinal Prospective Observational Study of the Characteristics, Treatment Patterns and Health Outcomes of Individuals with Severe Asthma in the United States
Condition: Severe Asthma
Purpose: To collect information on patient characteristics, treatment patterns, and health outcomes in patients with severe asthma.
Investigator: Gregory Neagos, MD

Retrospective and Prospective International EkoSonic Registry of the Treatment and Clinical Outcomes of Patients With Pulmonary Embolism
Condition: Pulmonary Embolism
To determine the treatment regimens used globally for EkoSonic therapy.
Investigator: Larry Diaz, MD


remede System Therapy Registry (reST Registry)
Condition: Central Sleep Apnea
The purpos
e of this registry is to collect safety and effectiveness data in participants with central sleep apnea implanted with the remede System.
Investigator: Matthew Sevensma, DO